NCT00460551 - Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL

Zalutumumab

8 mg/kg

DRUG

Induction chemotherapy

Combination of cisplatin and docetaxel administered as two cycles given every three weeks

RADIATION

Radiotherapy

64 Gy in 32 fractions over 6.5 weeks

Trial Locations (8)

CHR La Citadelle, Liège

CHU Sart-Tilman Domaine Universitaire du Sart-Tilman, Liège

UZ Gent, Ghent

Towson

CHRU Reims, Hospital Maison Blanche, Reims

Providence Portland Medical Center, Portland

VU Medisch Centrum (VUMC), Amsterdam

The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey